DPP

BLOCKCHAIN BRINGS THE FIGHT TO $40B FOOD FRAUD ECONOMY

Retrieved on: 
Thursday, April 6, 2023

OSLO, Norway, April 6, 2023 /PRNewswire/ --  In the aftermath of the recent false labeling controversy of foreign pork as British, the UK honey debacle, and a plethora of other cases, the prevalence of food fraud is at an all-time high. Renowned organisations have been impacted by serious food fraud incidents over the last decade. This 'shadow economy' currently impacts over 10% of the global supply chain and costs the industry $40billion annually, according to The Consumer Brands Association. 

Key Points: 
  • Renowned organisations have been impacted by serious food fraud incidents over the last decade.
  • It is not only the economic impact of food fraud, but also potential health consequences and knock-on, reputational damage for brands across the sector.
  • According to NFU Mutual , 72% of consumers believe there to be an issue with food fraud in the UK, and only 12% have confidence in the European food chain.
  • Food integrity has been a growing issue for policymakers, food systems, and consumers for many years.

Top Producing Suarez + Benz Joins Luxury Firm Deasy Penner Podley

Retrieved on: 
Thursday, March 30, 2023

LOS ANGELES, March 30, 2023 /PRNewswire/ -- Luxury real estate brokerage firm Deasy Penner Podley, (DPP) a select member of the Leading Real Estate Companies of the World Network, is thrilled to announce the addition of Chris Suarez, Kim Benz, Andrew Suarez and Christopher Suarez of Suarez + Benz to DPP. Suarez + Benz brings exceptional residential sales depth and experience to DPP and will act as an additional anchor to the expanding La Canada office.

Key Points: 
  • LOS ANGELES, March 30, 2023 /PRNewswire/ -- Luxury real estate brokerage firm Deasy Penner Podley, (DPP) a select member of the Leading Real Estate Companies of the World Network, is thrilled to announce the addition of Chris Suarez, Kim Benz, Andrew Suarez and Christopher Suarez of Suarez + Benz to DPP.
  • Suarez + Benz brings exceptional residential sales depth and experience to DPP and will act as an additional anchor to the expanding La Canada office.
  • In the business for 25 years, Kim Benz expresses "with Suarez + Benz, no detail is too small.
  • The addition of Suarez + Benz provides us with a cornerstone to grow both the office and the market."

Doosan Bobcat Announces Global Brand Strategy; Forklift, Portable Power and Industrial Air Transition to Bobcat Brand

Retrieved on: 
Thursday, March 9, 2023

Doosan Bobcat, Inc. , a company within Doosan Group, has announced its global branding strategy to create business and growth opportunities for the Doosan Bobcat product portfolio.

Key Points: 
  • Doosan Bobcat, Inc. , a company within Doosan Group, has announced its global branding strategy to create business and growth opportunities for the Doosan Bobcat product portfolio.
  • Doosan Portable Power (DPP) , an industry-leading global manufacturer of air compressors, mobile generators and light towers; Doosan Industrial Air (DIA) , one of the most comprehensive rotary air compressor lines on the market; and Doosan Industrial Vehicle (DIV) , a supplier of quality material handling equipment, including forklifts, will rebrand under the Bobcat trade dress in North America and applicable markets worldwide.
  • “Doosan Portable Power, Doosan Industrial Air and Doosan Industrial Vehicle have long legacies of developing high-quality products.
  • Bobcat-branded material handling equipment, industrial air compressors and portable power products are expected to be available for customer purchase through Doosan Bobcat’s extensive, global dealer network at a later date.

Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

Retrieved on: 
Friday, February 24, 2023

MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the DPP HIV-Syphilis System.

Key Points: 
  • MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the DPP HIV-Syphilis System.
  • “The DPP HIV-Syphilis System represents an exciting advancement in rapid testing for sexually transmitted infections.
  • Chembio’s DPP HIV-Syphilis System assists clinicians in diagnosing both HIV and syphilis while patients are still under care at the testing location.
  • The DPP HIV-Syphilis System is highly sensitive and specific, has a built-in procedural control, can be stored at room temperature, and has a 24-month shelf life.

Major League Soccer Launches MLS ADVANCE to Increase Hiring and Advancement of Underrepresented Candidates Across MLS Ecosystem

Retrieved on: 
Tuesday, February 21, 2023

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major League Soccer announced today the official unveiling of MLS ADVANCE -- a leading initiative in the league's strategy to increase inclusion and representation for underrepresented candidates for sporting positions across the MLS ecosystem and beyond.

Key Points: 
  • NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major League Soccer announced today the official unveiling of MLS ADVANCE -- a leading initiative in the league's strategy to increase inclusion and representation for underrepresented candidates for sporting positions across the MLS ecosystem and beyond.
  • MLS ADVANCE for sporting roles is an invitation-only professional development and networking series for candidates both inside and outside the MLS ecosystem who are ready to join or lead an MLS, MLS NEXT, or MLS NEXT Pro club.
  • The program has already had a tangible impact, with 42 percent of candidates participating in MLS ADVANCE having received job offers in sporting positions.
  • Networking Events with Key Decision Makers – MLS ADVANCE for sporting roles provides underrepresented job candidates and MLS decision makers with the opportunity to network and build relationships.

Global Glucagon-like Peptide 1 (GLP-1) Market Research Report 2023: Analysis of Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products - Forecasts to 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 30, 2023

In 2021, the global glucagon-like peptide 1 (GLP-1) market was valued at US$16.53 billion, and is probable to reach US$24.10 billion by 2027.

Key Points: 
  • In 2021, the global glucagon-like peptide 1 (GLP-1) market was valued at US$16.53 billion, and is probable to reach US$24.10 billion by 2027.
  • According to the report, the global glucagon-like peptide 1 (GLP-1) market is segmented into five products: Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products.
  • Global Glucagon-like Peptide 1 (GLP-1) Market Dynamics:
    Diabetes prevalence has risen faster in low- and middle-income countries than in high-income countries.
  • The glucagon-like peptide 1 (GLP-1) market is concentrated with the presence of a few number of players majorly dominating worldwide.

nChain and Unisot in Strategic Partnership to boost Supply Chain Traceability

Retrieved on: 
Thursday, February 16, 2023

LONDON, Feb. 16, 2023 /PRNewswire/ -- nChain, a global leader in the creation and delivery of Web3 solutions through Research and Development and the implementation of blockchain technology, today announces the signing of a strategic partnership agreement with UNISOT, a leading Platform as a Service enabling supply chain traceability.

Key Points: 
  • LONDON, Feb. 16, 2023 /PRNewswire/ -- nChain, a global leader in the creation and delivery of Web3 solutions through Research and Development and the implementation of blockchain technology, today announces the signing of a strategic partnership agreement with UNISOT, a leading Platform as a Service enabling supply chain traceability.
  • With UNISOT, we are particularly proud of being able to provide the technology for a solution that allows full transparency of the supply chain as well as 360 global interoperability from the source to the recycling point.
  • Stephan Nilsson, CEO and Co-founder, UNISOT, said: "nChain is the partner of choice for us for several reasons.
  • UNISOT's Web3 platform enables supply chain players of all sizes to participate in the global information flow, from small farmers to multinational giants to consumers.

nChain and Unisot in Strategic Partnership to boost Supply Chain Traceability

Retrieved on: 
Thursday, February 16, 2023

LONDON, Feb. 16, 2023 /PRNewswire/ -- nChain, a global leader in the creation and delivery of Web3 solutions through Research and Development and the implementation of blockchain technology, today announces the signing of a strategic partnership agreement with UNISOT, a leading Platform as a Service enabling supply chain traceability.

Key Points: 
  • LONDON, Feb. 16, 2023 /PRNewswire/ -- nChain, a global leader in the creation and delivery of Web3 solutions through Research and Development and the implementation of blockchain technology, today announces the signing of a strategic partnership agreement with UNISOT, a leading Platform as a Service enabling supply chain traceability.
  • With UNISOT, we are particularly proud of being able to provide the technology for a solution that allows full transparency of the supply chain as well as 360 global interoperability from the source to the recycling point.
  • Stephan Nilsson, CEO and Co-founder, UNISOT, said: "nChain is the partner of choice for us for several reasons.
  • UNISOT's Web3 platform enables supply chain players of all sizes to participate in the global information flow, from small farmers to multinational giants to consumers.

Medi-Cal Members Can Now Get Innovative Digital Programs to Prevent, Treat, Reverse Chronic Conditions

Retrieved on: 
Monday, January 23, 2023

LOS ANGELES and SAN DIEGO, Jan. 23, 2023 /PRNewswire/ -- Blue Shield of California Promise Health Plan is now offering its Medi-Cal members Wellvolution, a digitally based lifestyle medicine and mental health support program that can be personalized to address individual health needs and preferences.

Key Points: 
  • Created in collaboration with Solera Health, Wellvolution offers four pillars of health support through its app-based programs: disease prevention; chronic-condition reversal; mental health support; and tobacco cessation.
  • "Wellvolution improves access to care, which we know helps to close healthcare gaps for our members."
  • Wellvolution programs that Medi-Cal members can access include:
    Diabetes Prevention - A Centers for Disease Control and Prevention-approved Diabetes Prevention Program (DPP).
  • For more information about digital resources available to Medi-Cal members through Blue Shield's Wellvolution platform, go to wellvolution.com/medi-cal .

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

Retrieved on: 
Tuesday, January 31, 2023

STRASBOURG, France and HAUPPAUGE, N.Y., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc. (“Chembio”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that the companies have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio for $0.45 per share, representing a premium of 27% compared to the closing price of Chembio stock on January 30, 2023, in an all-cash transaction valued at $17.2 million.

Key Points: 
  • Biosynex will operate Chembio and its 100% owned German, Brazil and Malaysia subsidiaries as a wholly owned group.
  • “The acquisition of Chembio significantly advances our mission to develop, manufacture and market rapid diagnostics for screening, diagnosis and prevention to facilitate patient care and monitor health,” said Larry Abensur, Chief Executive Officer of Biosynex.
  • Under the terms of the merger agreement, Biosynex, through a subsidiary, will initiate a tender offer to acquire all outstanding shares of Chembio.
  • Craig-Hallum Capital Group LLC is acting as financial advisor and K&L Gates LLP is serving as legal counsel to Chembio.